Mechanism-Based Novel Antidotes for Organophosphate Neurotoxicity Doodipala Samba Reddy
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Monocrotophos Proposed AEGL Document
MONOCROTOPHOS Page 1 of 32 Proposed 10/2009 v.1 1 2 3 4 ACUTE EXPOSURE GUIDELINE LEVELS 5 (AEGLs) 6 7 8 PROPOSED 9 10 11 12 13 MONOCROTOPHOS 14 (CAS Reg. No. 6923-22-4) 15 16 17 18 19 20 MONOCROTOPHOS Page 2 of 32 Proposed 10/2009 v.1 1 2 PREFACE 3 4 Under the authority of the Federal Advisory Committee Act (FACA) P. L. 92-463 of 5 1972, the National Advisory Committee for Acute Exposure Guideline Levels for Hazardous 6 Substances (NAC/AEGL Committee) has been established to identify, review and interpret 7 relevant toxicologic and other scientific data and develop AEGLs for high priority, acutely toxic 8 chemicals. 9 10 AEGLs represent threshold exposure limits for the general public and are applicable to 11 emergency exposure periods ranging from 10 minutes to 8 hours. Three levels C AEGL-1, 12 AEGL-2 and AEGL-3 C are developed for each of five exposure periods (10 and 30 minutes, 1 13 hour, 4 hours, and 8 hours) and are distinguished by varying degree of severity of toxic effects. 14 The three AEGLs are defined as follows: 15 16 AEGL-1 is the airborne concentration (expressed as parts per million or milligrams per 17 cubic meter [ppm or mg/m3]) of a substance above which it is predicted that the general 18 population, including susceptible individuals, could experience notable discomfort, irritation, or 19 certain asymptomatic, non-sensory effects. However, the effects are not disabling and are 20 transient and reversible upon cessation of exposure. -
Downloads/Pgm Hydrus1d/HYDRUS-4.16.Pdf (Accessed on 20 April 2019)
water Article Assessment of the Environmental Risk of Pesticides Leaching at the Watershed Scale under Arid Climatic Conditions and Low Recharge Rates Hesham M. Ibrahim 1,2,* and Ali M. Al-Turki 1 1 Department of Soil Science, College of Food and Agricultural Sciences, King Saud University, P.O. Box 2460, Riyadh 11451, Saudi Arabia; [email protected] 2 Department of Soils and Water, Faculty of Agriculture, Suez Canal University, Ismailia 41522, Egypt * Correspondence: [email protected]; Tel.: +966-501728656 Received: 5 January 2020; Accepted: 2 February 2020; Published: 5 February 2020 Abstract: The assessment of the vulnerability of soil and groundwater resources to pesticide contamination is important to reduce the risk of environmental pollution. The applicability of the expanded attenuation factor (EAF) to assess leaching potential of 30 pesticides was investigated under 1 four recharge rates (0.0003–0.002 m d− ) in the arid environment of the Jazan watershed. EAF results revealed that Picloram, Carbofuran, Monocrotophos, and 2,4-D pesticides showed high leaching potential, mainly because of their low KOC, and relatively longer t1/2. In addition, medium leaching potential was observed with six more pesticides (Atrazine, Aldicarb, Simazine, Methomyl, Oxamyl, and Lindane). Regardless of the recharge rate, all other pesticides showed a very low leaching potential in the Jazan watershed. Sensitivity analysis revealed that the output of the EAF index is most sensitive to the fraction of organic carbon ( foc), water content at field capacity (θFC ), recharge rate (q), and partition coefficient (KOC), and least sensitive to soil bulk density (ρb) and air-filled porosity (na). -
Mechanisms of Action of Antiepileptic Drugs
Review Mechanisms of action of antiepileptic drugs Epilepsy affects up to 1% of the general population and causes substantial disability. The management of seizures in patients with epilepsy relies heavily on antiepileptic drugs (AEDs). Phenobarbital, phenytoin, carbamazepine and valproic acid have been the primary medications used to treat epilepsy for several decades. Since 1993 several AEDs have been approved by the US FDA for use in epilepsy. The choice of the AED is based primarily on the seizure type, spectrum of clinical activity, side effect profile and patient characteristics such as age, comorbidities and concurrent medical treatments. Those AEDs with broad- spectrum activity are often found to exert an action at more than one molecular target. This article will review the proposed mechanisms of action of marketed AEDs in the US and discuss the future of AEDs in development. 1 KEYWORDS: AEDs anticonvulsant drugs antiepileptic drugs epilepsy Aaron M Cook mechanism of action seizures & Meriem K Bensalem-Owen† The therapeutic armamentarium for the treat- patients with refractory seizures. The aim of this 1UK HealthCare, 800 Rose St. H-109, ment of seizures has broadened significantly article is to discuss the past, present and future of Lexington, KY 40536-0293, USA †Author for correspondence: over the past decade [1]. Many of the newer AED pharmacology and mechanisms of action. College of Medicine, Department of anti epileptic drugs (AEDs) have clinical advan- Neurology, University of Kentucky, 800 Rose Street, Room L-455, tages over older, so-called ‘first-generation’ First-generation AEDs Lexington, KY 40536, USA AEDs in that they are more predictable in their Broadly, the mechanisms of action of AEDs can Tel.: +1 859 323 0229 Fax: +1 859 323 5943 dose–response profile and typically are associ- be categorized by their effects on the neuronal [email protected] ated with less drug–drug interactions. -
8Th European Congress on Epileptology, Berlin, Germany, 21 – 25 September 2008
Epilepsia, 50(Suppl. 4): 2–262, 2009 doi: 10.1111/j.1528-1167.2009.02063.x 8th ECE PROCEEDINGS 8th European Congress on Epileptology, Berlin, Germany, 21 – 25 September 2008 Sunday 21 September 2008 KV7 channels (KV7.1-5) are encoded by five genes (KCNQ1-5). They have been identified in the last 10–15 years by discovering the caus- 14:30 – 16:00 ative genes for three autosomal dominant diseases: cardiac arrhythmia Hall 1 (long QT syndrome, KCNQ1), congenital deafness (KCNQ1 and KCNQ4), benign familial neonatal seizures (BFNS, KCNQ2 and VALEANT PHARMACEUTICALS SATELLITE SYM- KCNQ3), and peripheral nerve hyperexcitability (PNH, KCNQ2). The fifth member of this gene family (KCNQ5) is not affected in a disease so POSIUM – NEURON-SPECIFIC M-CURRENT K+ CHAN- far. The phenotypic spectrum associated with KCNQ2 mutations is prob- NELS: A NEW TARGET IN MANAGING EPILEPSY ably broader than initially thought (i.e. not only BFNS), as patients with E. Perucca severe epilepsies and developmental delay, or with Rolando epilepsy University of Pavia, Italy have been described. With regard to the underlying molecular pathophys- iology, it has been shown that mutations in KCNQ2 and KCNQ3 Innovations in protein biology, coupled with genetic manipulations, have decrease the resulting K+ current thereby explaining the occurrence of defined the structure and function of many of the voltage- and ligand- epileptic seizures by membrane depolarization and increased neuronal gated ion channels, channel subunits, and receptors that are the underpin- firing. Very subtle changes restricted to subthreshold voltages are suffi- nings of neuronal hyperexcitability and epilepsy. Of the currently cient to cause BFNS which proves in a human disease model that this is available antiepileptic drugs (AEDs), no two act in the same way, but all the relevant voltage range for these channels to modulate the firing rate. -
Photocatalytic Degradation of Monocrotophos and Chlorpyrifos In
Journal of Water Process Engineering 7 (2015) 94–101 Contents lists available at ScienceDirect Journal of Water Process Engineering journa l homepage: www.elsevier.com/locate/jwpe Photocatalytic degradation of monocrotophos and chlorpyrifos in aqueous solution using TiO2 under UV radiation ∗ Augustine Amalraj, Anitha Pius Department of Chemistry, The Gandhigram Rural Institute – Deemed University, Gandhigram, Dindigul 624 302, Tamil Nadu, India a r t i c l e i n f o a b s t r a c t Article history: Monocrotophos (MCP) and chlorpyrifos (CPS) are most popular and broadly used organophosphorous Received 6 November 2014 pesticides owing to its low cost and high efficiency in controlling pests in agriculture. Presence of Received in revised form 2 June 2015 pesticides in aquatic environments causes serious problems to human beings and other organisms. Photo- Accepted 2 June 2015 catalytic degradation has been proved to be a promising method for the treatment of water. In view of this, Available online 17 June 2015 TiO2 photocatalyst was prepared by sol–gel method and characterized by SEM with EDAX, XRD, BET and FTIR. The photocatalytic degradation of MCP and CPS was carried out using prepared TiO2 photocatalyst Keywords: irradiated with 16 W UV light source. The effect of various parameters, i.e., photocatalyst concentration, TiO2 nanoparticles Pesticides pesticide concentration and pH of the solution on the percentage of degradation of selected pesticides Monocrotophos had been examined. The kinetic analysis of photodegradation of MCP and CPS under different initial con- Chlorpyrifos centration followed the Langmuir–Hinshelwood model. TiO2 found to be an excellent photocatalyst for Langmuir–Hinshelwood model the degradation of MCP and CPS under UV light irradiation. -
Quantum Chemical Study of the Thermochemical Properties of Organophosphorous Compounds A
QUANTUM CHEMICAL STUDY OF THE THERMOCHEMICAL PROPERTIES OF ORGANOPHOSPHOROUS COMPOUNDS A. Khalfa, M. Ferrari, R. Fournet, B. Sirjean, L. Verdier, Pierre-Alexandre Glaude To cite this version: A. Khalfa, M. Ferrari, R. Fournet, B. Sirjean, L. Verdier, et al.. QUANTUM CHEMICAL STUDY OF THE THERMOCHEMICAL PROPERTIES OF ORGANOPHOSPHOROUS COMPOUNDS. Journal of Physical Chemistry A, American Chemical Society, 2015, 119 (42), pp.10527-10539. 10.1021/acs.jpca.5b07071. hal-01241498 HAL Id: hal-01241498 https://hal.archives-ouvertes.fr/hal-01241498 Submitted on 10 Dec 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. QUANTUM CHEMICAL STUDY OF THE THERMOCHEMICAL PROPERTIES OF ORGANOPHOSPHOROUS COMPOUNDS A. Khalfa, M. Ferrari1, R. Fournet1, B. Sirjean1, L. Verdier2, P.A. Glaude1 1Laboratoire Réactions et Génie des Procédés, Université de Lorraine, CNRS, 1 rue Grandville, BP 20451, 54001 NANCY Cedex, France, 2DGA Maîtrise NRBC, Site du Bouchet, 5 rue Lavoisier, BP n°3, 91710 Vert le Petit, France Abstract Organophosphorous compounds are involved in many toxic compounds such as fungicides, pesticides, or chemical warfare nerve agents. The understanding of the decomposition chemistry of these compounds in the environment is largely limited by the scarcity of thermochemical data. -
Ganaxolone (Epilepsy) – Forecast and Market Analysis to 2022
Ganaxolone (Epilepsy) – Forecast and Market Analysis to 2022 Reference Code: GDHC1071DFR Publication Date: February 2013 Executive Summary Epilepsy: Key Metrics in the Epilepsy Markets The below figure illustrates ganaxolone sales for the US 2022 Market Sales and 5EU during the forecast period. US $43.17m Sales for Ganaxolone by Region, 2022 5EU $4.64m Total $47.81m 10% 2012 Total: $47.81m Key Events (2012–2022) Level of Impact Launch of ganaxolone in the US in 2019 ↑↑↑ US Launch of ganaxolone in the 5EU in 2019 ↑↑↑ 5EU Source: GlobalData Sales for Ganaxolone in the Epilepsy Market GlobalData expects Marinus Pharmaceuticals to launch 90% ganaxolone in the US and EU in 2019. We estimate that 2022 sales of ganaxolone will reach $47.81m across Source: GlobalData these markets. Key factors affecting the uptake of ganaxolone will include: What Do the Physicians Think? Novel mechanism of action and good tolerability Overall physicians expressed a need for more AEDs profile and favorable opinions of those in pipeline Efficacy profile is not significantly different from that development. of other marketed anti-epileptic drugs (AEDs) “Among intractable epilepsy patients, any drug that helps Ganaxolone is still in early development; possible treat an additional segment of them will be used, and lack of funding to conduct Phase III trials necessary because we don’t have a basis for using one or another, for commercialization if it’s attractive, it will be used more.” [US] key opinion leader, November 2012 Heavy competition in the market “Brivaracetam is an interesting concept because it’s supposed to be “Super Keppra,” the follow-on from Keppra. -
Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Seizure 22 (2013) 589–600 Contents lists available at SciVerse ScienceDirect Seizure jou rnal homepage: www.elsevier.com/locate/yseiz Review Molecular mechanisms of antiseizure drug activity at GABAA receptors L. John Greenfield Jr.* Dept. of Neurology, University of Arkansas for Medical Sciences, 4301W. Markham St., Slot 500, Little Rock, AR 72205, United States A R T I C L E I N F O A B S T R A C T Article history: The GABAA receptor (GABAAR) is a major target of antiseizure drugs (ASDs). A variety of agents that act at Received 6 February 2013 GABAARs s are used to terminate or prevent seizures. Many act at distinct receptor sites determined by Received in revised form 16 April 2013 the subunit composition of the holoreceptor. For the benzodiazepines, barbiturates, and loreclezole, Accepted 17 April 2013 actions at the GABAAR are the primary or only known mechanism of antiseizure action. For topiramate, felbamate, retigabine, losigamone and stiripentol, GABAAR modulation is one of several possible Keywords: antiseizure mechanisms. Allopregnanolone, a progesterone metabolite that enhances GABAAR function, Inhibition led to the development of ganaxolone. Other agents modulate GABAergic ‘‘tone’’ by regulating the Epilepsy synthesis, transport or breakdown of GABA. GABAAR efficacy is also affected by the transmembrane Antiepileptic drugs chloride gradient, which changes during development and in chronic epilepsy. This may provide an GABA receptor Seizures additional target for ‘‘GABAergic’’ ASDs. GABAAR subunit changes occur both acutely during status Chloride channel epilepticus and in chronic epilepsy, which alter both intrinsic GABAAR function and the response to GABAAR-acting ASDs. -
Evaluation of Genotoxicity of Monocrotophos and Quinalphos In
Integrative Pharmacology, Toxicology and Genotoxicology Research Article ISSN: 2058-8496 Evaluation of genotoxicity of monocrotophos and quinalphos in rats and protective effects of melatonin Vibhuti Mishra, Sapneh Sharma, Shilpa Khatri and Nalini Srivastava* School of Studies in Biochemistry, Jiwaji University, Gwalior 474 011, India Abstract Monocrotophos [dimethyl-[E]-1-methyl-2-(methyl carbamoyl) vinyl phosphate, MCP] and quinalphos [O,O-diethyl-o-(2-quinoxymethyl)-phosphorothionate, QNP] are highly toxic, broad spectrum and cholinesterase inhibiting pesticides which are extensively used in agriculture and household. Acute and chronic exposure of these pesticides has adverse effects on living organisms. Present study was carried out to evaluate the genotoxic potential of these pesticides using comet assay and micronucleus assay in rats and also to analyze the protective effects of melatonin. Both acute and chronic exposure caused DNA damage in rat tissues and lymphocytes as evident from the statistically significant increase in DNA damage index on pesticide exposure. However the co-treatment of melatonin decreased the damage index to significant levels. At the same time, statistically significant number of micronuclei was observed in polychromatic erythrocytes (PCE) in the bone marrow of rats treated with pesticides when compared to control group but the co-treatment of melatonin decreased the number of micronucleated PCE in the pesticide treated rats. Hence, the co treatment of melatonin has the ability to reduce the genotoxic potential of MCP and QNP under the experimental conditions applied in the present study. Introduction is an inevitable consequence of cellular metabolism, with a propensity for increased levels following toxic insults due to exposure with Pesticides are highly toxic compounds extensively used for the various environmental chemicals, radiations, metals and pesticides. -
Effect of Ganaxolone on Seizure Frequency Across Subpopulations of Patients with CDKL5 Deficiency Disorder: Subgroup Analyses of the Marigold Study Elia M
Effect of Ganaxolone on Seizure Frequency Across Subpopulations of Patients With CDKL5 Deficiency Disorder: Subgroup Analyses of the Marigold Study Elia M. Pestana-Knight1; Alex Aimetti2; Joseph Hulihan2 1Epilepsy Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA; 2Marinus Pharmaceuticals, Inc., Radnor, PA, USA Table 1. Patient Baseline Demographics, Clinical Characteristics, Baseline allopregnanolone-sulfate (Allo-S) concentration Geographic region Introduction and Enrollment Location • Preliminary data from previous open-label clinical trials of GNX in genetic pediatric epilepsies • Ganaxolone performed directionally better than placebo across geographic regions analyzed suggest that lower plasma Allo-S concentrations may predict favorable antiseizure response (Figure 6) • CDKL5 deficiency disorder (CDD) is a rare, X-linked, epileptic encephalopathy with an estimated Placebo Ganaxolone a • No correlations between baseline Allo-S and response were observed in enrolled patients with − Ganaxolone demonstrated 36.7% MMSF difference in relation to placebo in the United States incidence of 1:40,000 to 1:60,000 live births1,2 (n = 51) (n = 49) CDD (Figure 3) (95% CI, 62.8%-7.2%) • Clinical phenotype of CDD is heterogenous but often includes early-onset refractory epilepsy, Age, n (%) − Future data from other clinical indications aim to provide further insights into the potential − Ganaxolone demonstrated 29.9% MMSF difference in relation to placebo in Australia, France, hypotonia, intellectual and gross motor impairment, and sleep disturbances 2-4 15 (29.4) 21 (42.9) 5-9 17 (33.3) 15 (30.6) utility of plasma Allo-S levels to predict response Israel, Italy, and the United Kingdom (95% CI, 82.2% to −12.6%) • The Marigold Study (NCT03572933) is the first phase 3, randomized, placebo-controlled trial to 10-19 19 (37.3) 13 (26.5) − Ganaxolone demonstrated 16.9% MMSF difference in relation to placebo in Russia and Poland evaluate adjunctive investigational ganaxolone (GNX) in patients with refractory epilepsy associated Gender, n (%) Figure 3. -
Monocrotophos Hazard Summary Identification Reason for Citation How to Determine If You Are Being Exposed Workp
Common Name: MONOCROTOPHOS CAS Number: 6923-22-4 RTK Substance number: 1313 DOT Number: UN 2783 Date: January 1987 Revision: November 1999 ----------------------------------------------------------------------- ----------------------------------------------------------------------- HAZARD SUMMARY WORKPLACE EXPOSURE LIMITS * Monocrotophos can affect you when breathed in and NIOSH: The recommended airborne exposure limit is quickly enters the body by passing through the skin. 0.25 mg/m3 averaged over a 10-hour workshift. * Exposure to Monocrotophos can cause rapid, severe, organophosphate poisoning with headache, dizziness, ACGIH: The recommended airborne exposure limit is blurred vision, tightness in the chest, sweating, nausea and 0.25 mg/m3 averaged over an 8-hour workshift. vomiting, diarrhea, muscle twitching, convulsions, coma and death. * The above exposure limits are for air levels only. When * Repeated exposure may cause personality changes of skin contact also occurs, you may be overexposed, even depression, anxiety or irritability. though air levels are less than the limits listed above. * Monocrotophos may affect the nervous system. WAYS OF REDUCING EXPOSURE IDENTIFICATION * Where possible, enclose operations and use local exhaust Monocrotophos is a reddish-brown crystalline (sugar or sand- ventilation at the site of chemical release. If local exhaust like) solid with a mild odor. It is also available as a liquid and ventilation or enclosure is not used, respirators should be is used as an insecticide. worn. * Wear protective work clothing. REASON FOR CITATION * Wash thoroughly immediately after exposure to * Monocrotophos is on the Hazardous Substance List Monocrotophos and at the end of the workshift. because it is cited by ACGIH, DOT, NIOSH and EPA. * Post hazard and warning information in the work area. -
Environmental Health Criteria 63 ORGANOPHOSPHORUS
Environmental Health Criteria 63 ORGANOPHOSPHORUS INSECTICIDES: A GENERAL INTRODUCTION Please note that the layout and pagination of this web version are not identical with the printed version. Organophophorus insecticides: a general introduction (EHC 63, 1986) INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY ENVIRONMENTAL HEALTH CRITERIA 63 ORGANOPHOSPHORUS INSECTICIDES: A GENERAL INTRODUCTION This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the United Nations Environment Programme, the International Labour Organisation, or the World Health Organization. Published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization World Health Orgnization Geneva, 1986 The International Programme on Chemical Safety (IPCS) is a joint venture of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization. The main objective of the IPCS is to carry out and disseminate evaluations of the effects of chemicals on human health and the quality of the environment. Supporting activities include the development of epidemiological, experimental laboratory, and risk-assessment methods that could produce internationally comparable results, and the development of manpower in the field of toxicology. Other activities carried out by the IPCS include the development of know-how for coping with chemical accidents, coordination